Esther L.
- Country
- Belgium
- Department
- Dermatology
Research Overview
- Evaluation of Dose Flexibility and Efficacy of Upadacitinib in Adults with Moderate to Severe Atopic Dermatitis: A Phase 3b/4 Randomized Study
- Phase 3 Randomized Study of Ruxolitinib Cream in Adults with Hidradenitis Suppurativa
- Efficacy and Safety of Ruxolitinib Cream in Pediatric Patients with Moderate Atopic Dermatitis: A Phase 3b Randomized, Double-Blind, Vehicle-Controlled Study
Data & Insights
Has run more than one trial at 76 of 202 partner sites.
Specializations
Dermatological Research
The investigator specializes in treating and studying moderate to severe plaque psoriasis, focusing on innovative therapeutic approaches in dermatology.
- Autoimmune skin conditions
- Inflammatory dermatoses
- Novel psoriasis treatments
Their clinical expertise extends to evaluating novel therapeutic agents for chronic skin conditions, particularly in the management of plaque psoriasis.
Immunological Focus
The investigator's work centers on immune-mediated skin disorders, with particular attention to the role of immunological pathways in psoriasis development.
- Immune system modulators
- Biological therapeutics
- Treatment efficacy assessment
Their research encompasses comparative analyses of various immunological interventions in dermatological conditions.
Clinical Assessment
The investigator has developed expertise in therapeutic efficacy evaluation for dermatological treatments, focusing on safety and effectiveness measurements.
- Treatment response monitoring
- Safety profile assessment
- Comparative therapeutic studies
Their work includes systematic evaluation of treatment outcomes in chronic skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.